Understanding Your Laboratory Test: A Patient Guide to Testing and Results

This test helps your healthcare provider evaluate how your body is functioning and look for signs of illness or infection. It is a common procedure that provides important information used to diagnose a condition, monitor an ongoing health problem, or guide decisions about your treatment plan.

The first trimester maternal screen with nuchal translucency is a prenatal screening test performed between 11 and 13 weeks of pregnancy. It combines two components: a blood test measuring pregnancy-related hormones and proteins, and an ultrasound measurement called nuchal translucency (NT), which measures the fluid buildup at the back of the baby's neck.

A trained member of our medical team will collect the required sample, which is usually a small amount of blood, urine, or another body fluid, following standard clinical procedures. The collection itself typically takes only a few minutes, and the sample is then sent to the laboratory for careful analysis by trained specialists.

The test involves two parts: First, a blood sample is taken from the mother's arm to measure levels of Pregnancy-Associated Plasma Protein A (PAPP-A) and free beta-hCG. Second, an ultrasound is performed to measure the nuchal translucency - the clear space at the back of the baby's neck. Babies with chromosomal conditions often have more fluid in this area. The results from both tests, along with your age and other factors, are combined to calculate your risk assessment.

Your results will be compared with established reference ranges to show whether your values fall within normal limits. Keep in mind that abnormal results do not always indicate a serious problem. Your doctor will review the findings with you, explain what they mean for your health, and discuss any follow-up testing or treatment that may be needed.

This test provides a risk assessment, not a definitive diagnosis. A "screen positive" result means your baby has a higher risk for certain conditions, but does not mean your baby definitely has a problem. Conversely, a "screen negative" result means your baby has a lower risk, but does not guarantee a healthy baby. Your healthcare provider will explain your specific results and discuss whether additional diagnostic testing (such as chorionic villus sampling or amniocentesis) is recommended.

This test is considered very safe, and serious complications are rare. You may experience minor, temporary discomfort, such as a brief sting during sample collection, slight bruising, or mild soreness at the site. Please tell your care team beforehand if you have a bleeding disorder, take blood thinners, or have any known allergies.

This is a screening test with no known risks to the mother or baby. The blood draw may cause minor bruising or discomfort, and the ultrasound uses sound waves which are considered safe during pregnancy. The test does not increase the risk of miscarriage.